Sensidose is a pharmaceutical company. The company has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The company's product portfolio includes a number of brands and drugs intended for the treatment of, for example, Parkinson's. The main operations are in the Nordic region.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| BWG Invest Sàrl (William Gunnarsson) | 11,61 | 11,61 | 2022-05-12 |
| Per Vasilis | 9,52 | 9,52 | 2022-05-12 |
| Lars-Åke Adolfsson | 7,88 | 7,88 | 2022-05-12 |
| Jungfrutomten Värdeinvest Aktiebolag | 6,82 | 6,82 | 2022-05-12 |
| Gerhard Dal | 4,59 | 4,59 | 2022-05-12 |
| Per Nilsson | 4,40 | 4,40 | 2022-05-11 |
| Christer Nyström | 3,86 | 3,86 | 2022-05-12 |
| Yvonne Håkansson | 3,86 | 3,86 | 2022-05-12 |
| Sten-Magnus Aquilonius | 2,32 | 2,32 | 2022-05-12 |
| Håkan Englund | 2,16 | 2,16 | 2022-05-12 |
2022-08-18 Delårsrapport 2022-Q2
2022-11-10 Delårsrapport 2022-Q3
2023-02-16 Bokslutskommuniké 2022